Geneva Partners LLC lessened its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 28.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 503 shares of the semiconductor company’s stock after selling 197 shares during the period. Geneva Partners LLC’s holdings in Synopsys were worth $244,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also modified their holdings of the company. Parnassus Investments LLC acquired a new position in Synopsys during the 3rd quarter worth about $633,469,000. Edgewood Management LLC boosted its stake in shares of Synopsys by 18.9% in the third quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock valued at $1,554,540,000 after purchasing an additional 487,025 shares during the period. Van ECK Associates Corp grew its holdings in shares of Synopsys by 26.5% in the third quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock valued at $791,923,000 after purchasing an additional 335,993 shares in the last quarter. Impax Asset Management Group plc increased its stake in Synopsys by 120.2% during the 3rd quarter. Impax Asset Management Group plc now owns 490,723 shares of the semiconductor company’s stock worth $248,497,000 after buying an additional 267,836 shares during the period. Finally, Wellington Management Group LLP raised its stake in shares of Synopsys by 32.5% in the third quarter. Wellington Management Group LLP now owns 1,048,709 shares of the semiconductor company’s stock valued at $531,056,000 after acquiring an additional 257,526 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Price Performance
Shares of SNPS opened at $528.42 on Thursday. Synopsys, Inc. has a 12-month low of $457.52 and a 12-month high of $629.38. The business’s fifty day moving average price is $514.82 and its 200 day moving average price is $519.39. The stock has a market capitalization of $81.68 billion, a PE ratio of 36.39, a price-to-earnings-growth ratio of 3.44 and a beta of 1.12.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on Synopsys
Insider Buying and Selling
In other news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares in the company, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.66% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- Roth IRA Calculator: Calculate Your Potential Returns
- Powering Profits: Utility Stocks That Shine in Volatility
- How Can Investors Benefit From After-Hours Trading
- Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead?
- Golden Cross Stocks: Pattern, Examples and Charts
- RTX and Lockheed Martin: Buy 1 for Today and 1 for Tomorrow
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.